Oculus Innovative Sciences, Inc. Logo

Email this page: News Release

Sonoma Pharmaceuticals Receives Two New United Arab Emirates Regulatory Approvals: Pediacyn® For Atopic Dermatitis And Epicyn® For Scar Management

® For Atopic Dermatitis And Epicyn® For Scar Management" />
 

Separate multiple addresses with commas. Maximum 200 characters.
 
 


These email addresses will be used to email the page on your behalf and will not be used by Oculus Innovative Sciences, Inc. for any marketing purposes.

Send:       


 
This helps Oculus Innovative Sciences, Inc. prevent automated submissions.